What are the reactions after discontinuation of sotorasib (AMG510)?

Sotoracib (AMG510) is a targeted drug used to treat advanced non-small cell lung cancer (NSCLC) with KRAS gene mutations. Patients may experience some reactions and changes after stopping the drug. Here are some possible scenarios:

1. Tumor progression: After stopping the use of sotoraxib, the tumor may grow or spread again. This situation may be related to the gradual weakening of the therapeutic effect of sotorasib. Patients should pay close attention to changes in the tumor and undergo regular examinations after stopping the drug.

2. Alleviation of side effects: Sotoracib may cause some side effects, such as nausea, vomiting, fatigue, diarrhea, etc. These side effects may gradually lessen or disappear after you stop taking the medicine. Patients should report changes in side effects to their doctors so they can be treated promptly.

3. Disease progression: NSCLC is a late-stage cancer, and the disease may continue to progress even if sotoracib is used. After the medication is stopped, the tumor may grow again and new symptoms may appear. Patients should pay close attention to physical changes and communicate with their doctors in a timely manner.

4. Alternative treatment: If the tumor progresses or other problems occur after stopping sotorasib, your doctor may consider other treatment options. Depending on the patient's specific circumstances, chemotherapy, immunotherapy, or other targeted therapies may be recommended.

5. Psychological impact: After stopping the drug, patients may face psychological stress and anxiety. Discontinuation of sotorasiib, an effective treatment, may bring uncertainty and concern. During this process, patients should stay in close contact with their doctor and support team for support and guidance.

In summary, patients may experience changes in tumor progression, side effect relief, disease progression, alternative treatments, and psychological effects after discontinuation of sotorasiib. Each patient's situation is unique, so decisions about discontinuation and subsequent treatment options require in-depth discussion and shared decision-making with your physician. By promptly reporting any physical or psychological changes and closely following your doctor's advice and guidance, you can better manage and control the progression of the disease.